Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Kiniksa Pharmaceuticals International, plc KNSA

Healthcare  —  Drug Manufacturers Specialty & Generic
75.08 (0.26) (0.35%) as of 25 Sep
Market cap
$5.9B
P/E
70.2×
Cash Flow Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 51.56 0.00 97.53 5.47 0.00 — — — — —
P/S ratio 4.52 3.34 4.80 4.55 0.00 — — — — —
P/FCF ratio 22.42 55.34 97.89 177.86 0.00 — — — — —
P/Operating CF 56.79 75.27 300.16 (86.55) (42.74) — — — — —
P/B ratio 5.39 3.22 2.96 2.53 4.36 — — — — —
Price to Tangible BV 5.54 3.35 3.08 2.65 4.87 — — — — —
EV/Sales 3.91 2.76 4.04 3.68 0.00 — — — — —
EV/EBITDA 33.60 0.00 0.00 66.63 0.00 — — — — —
EV/Operating CF 19.18 45.51 82.09 139.71 (4.95) — — — — —
EV/FCF 19.39 45.80 82.33 144.02 (4.26) — — — — —
Quick Ratio 3.09 2.84 3.58 4.32 4.15 10.16 8.39 7.22 2.62 24.36
Current Ratio 3.79 3.30 4.34 5.16 4.38 10.46 8.68 7.37 2.70 24.47
Net Debt/EBITDA (5.26) 5.55 9.03 (15.66) 1.18 2.09 1.39 2.85 0.70 2.34
Debt/Assets 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Asset Turnover 1.01 0.76 0.55 0.64 0.13 0.00 0.00 0.00 0.00 0.00
Operating CF/Net income 2.34 (0.59) 0.94 0.03 0.80 0.85 0.98 0.78 0.77 0.91
Capex/Depreciation (1.01) (0.15) (0.06) (0.01) (8.67) (0.12) (1.55) (18.50) (2.46) (0.14)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE 11.73% (9.85%) 3.37% 63.10% (63.55%) (60.06%) (64.15%) (108.91%) 112.39% 41.53%
ROA 8.78% (7.80%) 2.86% 52.96% (54.24%) (53.44%) (56.16%) (55.88%) (124.80%) (46.12%)
ROIC 31.44% (14.63%) (6.77%) 2.97% (3,451.96%) 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets 15.13% (18.63%) 6.60% 92.77% (102.25%) (52.83%) (73.51%) (37.19%) (217.70%) (44.30%)
Average Days of Receivables 8.40 35.98 28.72 20.99 37.74 — — — — —
Research and Development Expense of Revenue 14.29% 26.37% 28.16% 29.74% 257.62% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue 28.97% 39.70% 47.89% 44.49% 222.99% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets 0.02 0.03 0.03 0.04 0.08 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue 5.46% 7.25% 10.05% 11.41% 65.31% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets 0.11 0.13 0.15 0.18 0.18 — — — — —
Graham Number 11.73 0.00 5.17 18.42 0.00 — — — — —
Earnings Yield 1.94% (3.08%) 1.03% 18.28% (19.54%) — — — — —
Free Cash Flow Yield 4.46% 1.81% 1.02% 0.56% (18.18%) — — — — —
Revenue per Share 9.13 5.93 3.86 3.17 0.56 0.00 0.00 0.00 0.00 0.00
Operating CF per Share 1.86 0.36 0.19 0.08 (1.84) (2.21) (2.93) (2.74) (27.75) (83.56)
Capex per Share (0.02) 0.00 0.00 0.00 (0.30) 0.00 (0.06) (0.18) (0.04) (0.01)
Free Cash Flow per Share 1.84 0.36 0.19 0.08 (2.14) (2.21) (2.99) (2.92) (27.78) (83.57)
Cash per Share 5.58 3.41 2.95 2.75 2.66 5.23 4.32 10.40 25.23 214.27
Shareholders Equity per Share 7.65 6.14 6.26 5.71 2.70 5.04 4.17 9.45 16.61 206.97
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 7.65 6.14 6.26 5.71 2.70 5.04 4.17 9.45 16.61 206.97
Free Cash Flow 136.42 25.44 13.17 5.79 (146.71) (136.81) (161.57) (86.30) (50.29) (21.87)
Working Capital 387.99 231.18 212.63 195.99 151.62 301.40 213.80 271.20 29.67 54.03
Capital Expenditures (1.57) (0.25) (0.13) (0.01) (20.41) (0.28) (3.20) (5.29) (0.07) 0.00
Net Current Asset Value 331.15 189.68 188.81 179.54 148.68 295.72 212.52 271.05 29.67 54.03
EV/EBIT 34.27 0.00 0.00 83.01 0.00 — — — — —
Capex to Sales 0.00 0.00 0.00 0.00 0.53 0.00 0.00 0.00 0.00 0.00
Net Profit Margin 8.71% (10.21%) 5.21% 83.28% (409.72%) 0.00% 0.00% 0.00% 0.00% 0.00%
Price to Operating Income 39.64 0.00 0.00 102.51 0.00 — — — — —
Other line items
Depreciation/Fixed assets 0.80 2.56 3.19 1.45 0.83 0.59 0.32 0.05 0.22 0.26
Cash ROIC 13.86% 3.67% 1.95% 0.71% (35.16%) (22.12%) (35.91%) (14.89%) (66.49%) (19.91%)
Accounts Receivable Turnover 23.64 13.44 15.93 26.46 0.00 — — — — —
Accounts Payable Turnover 38.20 11.84 4.14 4.69 7.68 1.23 0.39 0.05 0.04 0.03
Inventory Turnover 1.91 2.12 1.27 1.81 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables 9.53 12.22 90.09 125.93 74.93 48.25 633.71 13,933.81 15,877.50 3,517.27
Days of Inventory on Hand 257.96 157.98 340.03 344.34 147.40 0.00 0.00 0.00 0.00 0.00
Average Receivables 28.66 31.50 16.96 8.32 — — — — — —
Average Payables 2.03 5.14 8.07 4.88 1.19 3.10 8.31 6.07 0.72 0.72
Average Inventory 40.63 28.74 26.36 12.64 — — — — — —
Average Assets 672.09 553.44 493.00 346.24 291.13 302.00 288.25 184.73 51.98 51.98
Average Common Equity 503.02 438.64 417.49 290.59 248.49 268.68 252.35 94.78 (57.72) (57.72)

Fold the line items

Columns are period end dates